Patricia J. Zettler, JD is an associate professor at The Ohio State University Moritz College of Law and a member of Ohio State’s Drug Enforcement and Policy Center and its Comprehensive Cancer Center. Her research and teaching focus on FDA law and policy, torts, and legislation and regulation. Her scholarship has appeared in leading legal and health sciences journals such as the Indiana Law Journal, the Boston College Law Review, JAMA, JAMA Oncology, and Science, and has covered various topics including stem cell interventions, gene therapy, opioids, cannabis products, tobacco and nicotine products, and COVID-19 countermeasures. She also currently serves on the National Academies of Sciences, Engineering, and Medicine Committee on Reviewing the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE), the Presidential Task Force on the Use of Unproven and/or Unethical Cell & Gene Therapies for the International Society of Cell & Gene Therapy, and the Black Lives Matter Advisory Committee for the Food and Drug Law Institute. Before entering academics, Zettler served as an associate chief counsel in the Office of the Chief Counsel at FDA. She received her undergraduate and law degrees from Stanford University, both with distinction.